Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    July 2022
  1. SHAH N, Ghazi L, Yamamoto Y, Martin M, et al
    Rationale and Design of a Pragmatic Trial Aimed at Improving Treatment of Hyperlipidemia in Outpatients with Very High Risk Atherosclerotic Cardiovascular Disease: A PRagmatic Trial Of Messaging to Providers about Treatment of HyperLIPIDemia (PROMPT-L
    Am Heart J. 2022 Jul 13. pii: S0002-8703(22)00146.
    PubMed     Abstract available

    May 2022
  2. PERSSON LINDELL O, Karlsson LO, Nilsson S, Charitakis E, et al
    Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care.
    Am Heart J. 2022;247:132-148.
    PubMed     Abstract available

    October 2021
  3. REDDY NK, Kaushal V, Kanaya AM, Kandula NR, et al
    Cardiovascular risk factor profiles in North and South Indian and Pakistani Americans: The MASALA Study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00367.
    PubMed     Abstract available

    May 2021
  4. SHI X, He J, Lin M, Liu C, et al
    Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00111.
    PubMed     Abstract available

    January 2021
  5. YANKEY GS, Jackson LR, Marts C, Chiswell K, et al
    African American-Caucasian American Differences in Aortic Valve Replacement in Patients with Severe Aortic Stenosis: Racial Differences in AVR.
    Am Heart J. 2021 Jan 13. pii: S0002-8703(21)00009.
    PubMed     Abstract available

  6. ZACHARIAH JP, Shittu T, Wang Y
    Lipid temporal trends in normal-weight youth.
    Am Heart J. 2021;231:68-72.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.